Patents for C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648) |
---|
10/21/2014 | US8865891 Optically-detectable enzyme substrates and their method of use |
06/04/2014 | CN103833774A Method of recovering effective components from potassium clavulanate mixed powder |
03/26/2014 | EP2710016A1 Regulation of nitric oxide release and biofilm development |
03/19/2014 | CN103649098A Regulation of nitric oxide release and biofilm development |
12/31/2013 | US8618285 Triazole derivatives |
09/18/2013 | CN103304583A Method for recovering clavulanic acid from clavaminic acid salt crystallization mother liquor |
04/11/2013 | US20130090470 Optically-detectable enzyme substrates and their method of use |
12/26/2012 | CN102838624A Method for purifying clavulanic acid from fermentation liquor |
11/27/2012 | US8318450 Optically-detectable enzyme substrates and their method of use |
11/22/2012 | WO2012155203A1 Regulation of nitric oxide release and biofilm development |
11/22/2012 | CA2835642A1 Regulation of nitric oxide release and biofilm development |
02/21/2012 | US8119795 Triazole derivatives II |
02/16/2012 | US20120040380 Optically-detectable enzyme substrates and their method of use |
01/10/2012 | CA2408853C Process |
08/31/2011 | EP1489061B1 Process for producing cyclic compound |
07/06/2011 | EP1165049B2 Agglomerates by crystallisation |
02/24/2011 | US20110045082 Agglomerates by crystallisation |
02/01/2011 | CA2364342C Agglomerates by crystallisation |
10/12/2010 | US7812014 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections |
08/03/2010 | US7767823 washing, crystallizing |
05/26/2010 | CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors |
04/06/2010 | US7691842 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors |
03/30/2010 | CA2424462C Clavulanic acid pharmaceutical compositions |
01/28/2010 | US20100022540 Triazole derivatives ii |
05/06/2009 | CN100484943C Novel method for preparing clavulanate |
04/28/2009 | CA2425314C Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
12/25/2008 | US20080318921 5R,6Z)-6-(Imidazo[2,1-b][1,3]benzothiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; beta -Lactamases hydrolyze beta -lactam antibiotics and as such serve as the primary cause of bacterial resistance |
12/18/2008 | US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections |
12/02/2008 | US7459551 Method for preparing cyclic compounds |
11/05/2008 | EP1988093A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
10/08/2008 | CN101279982A Novel method for preparing clavulanate |
09/10/2008 | EP1284978B2 Process for the purification of a salt of clavulanic acid |
07/23/2008 | EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids |
05/06/2008 | CA2237763C Production of a salt of clavulanic acid |
04/08/2008 | CA2182504C Process for the preparation of a salt of clavulanic acid |
04/01/2008 | CA2210748C Clavulanic acid extraction process |
03/18/2008 | US7344869 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and Streptomyces hosts capable of improved clavulanic acid production |
12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
11/21/2007 | EP0970087B1 A process for the preparation of a metal salt of clavulanic acid |
11/13/2007 | CA2286369C A process for the preparation of a metal salt of clavulanic acid |
07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
06/14/2007 | CA2783572A1 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
04/25/2007 | CN1312086C Process for producing cyclic compound |
10/18/2006 | EP1711504A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample |
09/28/2006 | US20060217361 Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors |
09/26/2006 | US7112582 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
08/08/2006 | US7087748 Process |
08/02/2006 | CN1267437C Pharmaceutical compositions |
06/07/2006 | CN1258535C Process for preparation of metal salt of clavulanic acid |
06/06/2006 | USH2158 Process for the production of clavulanic acid salts |
04/13/2006 | US20060079676 washing, crystallizing |
04/13/2006 | US20060079496 Agglomerates by crystallisation |
03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
12/27/2005 | US6979735 Agglomerates by crystallization |
12/15/2005 | WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
12/14/2005 | EP0970198B1 Micro-organisms with increased production of clavulanic acid |
12/07/2005 | EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
11/16/2005 | CN1696301A Process for clavulanic acid production by microbial thallus |
10/13/2005 | US20050227309 Optically-detectable enzyme substrates and their method of use |
10/12/2005 | CN1222528C Process for purification of salt of clavulanic acid |
09/22/2005 | US20050209450 High yield for industrial production; beta -lactam antibacterial agents; allyl (5R,6S)-6((R)-1-t-butyldimethyl-silyloxyethyl)-7-oxo-3-((R)-2-tetrahydrofuryl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate (3-2) |
09/21/2005 | CN1219512C Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
08/30/2005 | US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production |
08/17/2005 | CN1656046A Process for producing cyclic compound |
08/04/2005 | WO2005071096A2 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample |
08/03/2005 | CN1649883A Bicyclic 6-alkylidene-penems as lactamases inhibitors |
07/06/2005 | CN1209099C Agglomerates by crystallisation |
04/27/2005 | CN1198940C Fermentation of clavulanic acid at a controlled level of ammonia |
03/31/2005 | US20050070519 Cyclisation process for the preparation of c-2 beta-lactam compounds |
03/09/2005 | CN1192107C 5S clavate alkyl gene separated from rhabdion streptomycete and its application in clavulanic acid production |
01/26/2005 | EP1499621A1 Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors |
12/29/2004 | EP1328528B1 Pharmaceutical compositions comprising clavulanic acid |
12/22/2004 | EP1489061A1 Process for producing cyclic compound |
11/25/2004 | DE4307422B4 Verfahren zur Herstellung von Clavulansäuresalzen Process for the preparation of salts of clavulanic acid |
11/03/2004 | EP1319086B1 Process for the preparation of clavulanic acid |
09/15/2004 | EP1456393A1 Cyclisation process for the preparation of c-2 beta-lactam compounds |
09/08/2004 | EP0813536B1 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid |
08/18/2004 | EP1284978B1 Process for the purification of a salt of clavulanic acid |
04/22/2004 | US20040077622 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
04/08/2004 | US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
04/01/2004 | US20040063930 Selective adsorption |
03/17/2004 | EP0804441B1 Clavulanic acid extraction process |
03/04/2004 | US20040043981 Pharmaceutical composistions |
03/04/2004 | US20040043980 Bactericides; storage stability |
02/25/2004 | EP1165049B1 Agglomerates by crystallisation |
02/18/2004 | EP0874855B1 Production of a salt of clavulanic acid |
02/17/2004 | US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
01/21/2004 | CN1469880A Pharmaceutical compositions |
01/21/2004 | CN1469744A Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
12/03/2003 | CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor |
11/27/2003 | US20030219867 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
11/13/2003 | WO2003093279A1 BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS |
11/13/2003 | CA2483538A1 Bicyclic 6-alkylidene-penems as .szlig.-lactamases inhibitors |
10/30/2003 | US20030203886 Process for the production of clavulanic acid salts |
10/07/2003 | CA2208520C Diclavulanate salt with a diamino ether and process of preparation |
10/02/2003 | WO2003080543A1 Process for producing cyclic compound |
09/04/2003 | US20030166175 Process for clavulanic acid production |
09/03/2003 | EP0941229B1 Purification of fermented clavulanic acid |